logo
#

Latest news with #Cranbury

Integris Amplifies Position as a Leading Future-Ready MSP with Strategic Acquisition
Integris Amplifies Position as a Leading Future-Ready MSP with Strategic Acquisition

Yahoo

time14 hours ago

  • Business
  • Yahoo

Integris Amplifies Position as a Leading Future-Ready MSP with Strategic Acquisition

National managed IT services provider advances vision for differentiated service offerings and organizational growth with expanded footprint CRANBURY, N.J., June 16, 2025 /PRNewswire/ -- Integris, a national leader in future-ready managed services, backed by OMERS Private Equity, today announces the acquisition of premier managed service provider, TechMD along with its security division, 1nteger Security. This strategic acquisition is its largest to date and signifies the next pivotal milestone in Integris' continued evolution by expanding the company's innovative solutions and services that drive digital maturity for small to midsize businesses. "Every acquisition we make is a strategic step toward our vision of transforming Integris into a smarter, faster, and more transformative digital powerhouse," said Glenn Mathis, newly appointed CEO, and previous president and COO, of Integris. "By bringing like-minded teams and capabilities into the Integris family, we're not just expanding our footprint—we're deepening our ability to elevate the customer experience. Together, we will deliver a high-impact platform that's more responsive, more secure, and more aligned with the real needs of our clients." Founded in 1986 as ICS and rebranded to TechMD in 2023, the Northeast-based managed service provider—with a strong presence in California—has been helping small to midsize businesses and organizations power their success through technology for more than 20 years. This extensive knowledge and expertise in providing IT managed services, cybersecurity services, technical services, cloud solutions and product procurement will assist in advancing Integris' vision for the future of the industry. "Our mission has been to develop a technology company that is future-ready and forward-thinking with a strong sense of duty toward the customer experience, and we believe Integris is the perfect representation of this direction," said Kevin Blake, president and CEO of TechMD. "Integris and its leadership are in the right position to elevate our combined experience and technology solutions to the next level, and we're thrilled to be joining their team." This pivotal moment in Integris' history also marks the progression of leadership for the company. After founding and leading the company since its inception, Rashaad Bajwa is transitioning from CEO to executive chairman of the Integris Board. "It has been the privilege of my life to help build Integris into what it is today, however, I cannot think of a more perfect fit for the future of Integris than Glenn," said Bajwa. "Our industry is undergoing exciting changes, with Integris at the forefront of this innovative charge, and with Glenn's powerful thought leadership on how AI, automation and data will transform the MSP of the future, now is the perfect time for him to take over the reigns as CEO and for me to help support Integris from my position on the Board." To learn more about Integris' suite of solutions and services, visit Guggenheim Securities, LLC acted as exclusive financial advisor to TechMD. About IntegrisIntegris is a national leader in future-ready managed services, delivering innovative solutions that drive digital maturity for small to midsize businesses. We go beyond traditional IT management by delivering strategic roadmaps that optimize operations, strengthen cybersecurity, refine cloud solutions, and ensure compliance—all while enhancing our client's digital capabilities. Our goal is to transform each organization into a smarter and faster digital powerhouse. Our platform is responsive, secure, and ready to meet the unique regulatory demands of the industries we serve. Regularly featured on the Inc. 5000 list of fastest-growing companies, Integris is backed by the private equity arm of the Ontario Municipal Employees Retirement System (OMERS). For more information, visit About OMERSOMERS Private Equity manages investments globally on behalf of OMERS, one of Canada's largest defined benefit pension plans, with C$138.2 billion in net assets as of December 31, 2024, including approximately C$27.5 billion in net private equity investment asset exposure. The Buyout team invests across Industrials, Healthcare, Business Services and Technology, deploying an evergreen capital base to partner with strong management teams and transform good companies into industry leaders. For more information, please visit View original content to download multimedia: SOURCE Integris

FDA will allow three new color additives made from minerals, algae and flower petals
FDA will allow three new color additives made from minerals, algae and flower petals

Associated Press

time09-05-2025

  • Health
  • Associated Press

FDA will allow three new color additives made from minerals, algae and flower petals

U.S. regulators said Friday that they would allow three new color additives made from natural sources to be used in the nation's food supply. It comes after health officials pledged a sweeping phase-out of petroleum-based dyes widely used in foods from cereals to sports drinks to boost health — though action is still pending. The Food and Drug Administration said it is granting petitions to allow galdieria extract blue, a blue color derived from algae; calcium phosphate, a white color derived from a naturally occurring mineral; and butterfly pea flower extract, a blue color made from dried flower petals. The colors will be approved for use in a range of foods from fruit drinks and yogurt to pretzels, ready-to-eat chicken and candies. The move 'will expand the palette of available colors from natural sources for manufacturers to safely use in food,' FDA officials said in a statement. Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies indicating the dyes can cause neurobehavioral problems for some children, including hyperactivity and attention issues. The FDA has maintained for decades that the approved dyes are safe and that 'the totality of scientific evidence shows that most children have no adverse effects when consuming foods containing color additives.' The new color approvals include a 2021 petition from the French company Fermentalg to allow galdieria extract blue; a 2023 petition from Innophos Inc. of Cranbury, New Jersey, to allow calcium phosphate; and a 2024 petition from Sensient Colors LLC of St. Louis, Missouri, to allow butterfly pea flower extract. The approvals are set to be published in the federal register on May 12 and would take effect in June. In April, Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary announced that they would take steps to eliminate synthetic food dyes in the U.S. food supply by the end of 2026, largely through voluntary efforts from the food industry. The officials also said they would revoke authorization for two little-used artificial dyes, Citrus Red No. 2 and Orange B, and accelerate the timeline to remove Red 3, a food color banned in January because of a link to cancer in laboratory rats. The FDA plans to initiate the process to revoke those colors 'within the coming months,' a spokesperson for the Department of Health and Human Services said. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store